<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04499040</url>
  </required_header>
  <id_info>
    <org_study_id>2016-42</org_study_id>
    <nct_id>NCT04499040</nct_id>
  </id_info>
  <brief_title>Clinical and Biological Characterization of Patients and Collection of Samples</brief_title>
  <acronym>THE-RNA</acronym>
  <official_title>Tricho-hepato-enteric Syndrome: From Abnormal RNA Decay to Disease Clinical and Biological Characterization of Patients and Collection of Samples -THE-RNA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives: Collect clinical and biological data about patients with SD/THE, collect samples&#xD;
      of patients; create a secure on line database to collect worldwide data about SD/THE Partners&#xD;
      : APHM, HCL, APHP&#xD;
&#xD;
      Currently10 patients (8 with TTC37 mutations and 2 with SKIV2l mutations) present a SD/THE&#xD;
      and are managed in France in 5 different centers (Marseille, Paris Trousseau, Paris Necker,&#xD;
      Paris Robert Debrés, and Lyon). Most of them are followed in hepato-gastro-enterology units&#xD;
      for their intractable diarrhea. Three aspects of the disease: intractable diarrhea, immune&#xD;
      defect and liver disease are responsible for the main part of the burden of the disease .For&#xD;
      each aspect, the investigators will propose a close follow-up with collection of clinical,&#xD;
      biochemical, functional and microbial data.&#xD;
&#xD;
      Collect of clinical date: during a programmed consultation clinical data about symptom will&#xD;
      be collected twice a year. A detailed form will be used for better delineation of the&#xD;
      symptoms. These data included growth, symptom (diarrhea, pain …), and clinical signs. Most of&#xD;
      these children have recurrent sample for follow up. During them some blood will be take for&#xD;
      study the immune side but also the platelet function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of detailed clinical characteristics of the phenotype of Tricho-hepato-enteric syndrome</measure>
    <time_frame>3 years</time_frame>
    <description>Existence or absence of 9 clinical signs suggestive of Tricho-hepato-enteric syndrome, to know:&#xD;
neonatal characteristics,&#xD;
existence or not of the 9 clinical signs suggestive of the disease,&#xD;
initial symptoms and chronology leading to the diagnosis,&#xD;
organ damage,&#xD;
nutrition,&#xD;
treatment,&#xD;
growth,&#xD;
dermatological evaluation,&#xD;
hepatic evaluation,&#xD;
neuropsychological evaluation (score of WPPSI-III, WISC-IV, WAIS-IV),&#xD;
quality of life scale (VSPA in children between 3 and 17 years old and WHOQUOL in adults),&#xD;
self-report anxiety scale (STAI in children over 8 years)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tricho Hepato Enteric Syndrome</condition>
  <arm_group>
    <arm_group_label>patients with SD/THE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Blood samples to assess biological parameters such as:</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>patients with SD/THE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fecal samples</intervention_name>
    <description>Microbiota analysis</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>patients with SD/THE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuropsychological</intervention_name>
    <description>Neuropsychological assessment</description>
    <arm_group_label>patients with SD/THE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient &lt; 18 year-old&#xD;
&#xD;
          -  patients with SD/THE&#xD;
&#xD;
        control group :&#xD;
&#xD;
          -  patients with tufting enteropathy and short bowel syndrome.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  child among whom the parents or the legal representatives refused that their child&#xD;
             participates in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Olivier Arnaud</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexandre FABRE</last_name>
    <phone>491382747</phone>
    <phone_ext>+33</phone_ext>
    <email>alexandre.fabre@ap-hm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DRS AP-HM, Sponsor</last_name>
    <phone>491382747</phone>
    <phone_ext>+33</phone_ext>
    <email>drci@ap-hm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>ALEXANDRE FABRE</last_name>
      <email>alexandre.fabre@ap-hm.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 31, 2016</study_first_submitted>
  <study_first_submitted_qc>July 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2020</study_first_posted>
  <last_update_submitted>July 30, 2020</last_update_submitted>
  <last_update_submitted_qc>July 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Growth Retardation</mesh_term>
    <mesh_term>Hair Diseases</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea, Infantile</mesh_term>
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

